Back to Research Hub
PTC Therapeutics, Inc.
PTCT
$78.40-0.10 (-0.13%)
PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders.
StreetsValue research for PTC Therapeutics, Inc. (PTCT)
Members get the full report for PTC Therapeutics, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.